NMPN Care Programme 2017
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Welcome to our new homepage
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Contact
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Introduction
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
A non-interventional, post authorisation safety study to continously monitor safety and pregnancy outcomes in a cohort of at-risk ET subjects exposed to Xagrid compared to other conventional cytoreductive therapies (EXELS)
A long-term observational study assessing the safety of anagrelide (Xagrid) in ET patients, comparing outcomes with hydroxycarbamide-treated patients over 10 years. Inclusion closed in 2009; follow-up ongoing.
A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia. EudraCT # 2007-005306-49
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Alpha-Interferon therapy of Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
A Danish retrospective study investigating JAK2 allele burden in PV, ET, and PMF patients before and after interferon therapy, aiming to validate blood and bone marrow correlation.
Prospective study of Quality-of-Life in newly diagnosed MPN patients
A Swedish study led by Peter Johansson assessing quality of life in MPN patients from diagnosis through three years, using EORTC QLQ-C30 and MPN-SAF tools.
